Jeffrey A. Lieberman, MD

Dr. Jeffrey A. Lieberman is a distinguished member of the Editorial Advisory Board of Psychopharmacology Bulletin and a leading authority on schizophrenia research, psychopharmacology, and clinical psychiatry. He serves as the Constance and Stephen Lieber Professor of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons, Director of the New York State Psychiatric Institute, and Psychiatrist-in-Chief at Columbia University Medical Center of the NewYork-Presbyterian Hospital.

Research Excellence

Dr. Lieberman’s groundbreaking work has significantly advanced our understanding of the natural history and pathophysiology of schizophrenia, as well as the pharmacology and clinical effectiveness of antipsychotic drugs. His research has directly influenced treatment protocols and improved outcomes for patients with severe mental illness worldwide.

He has authored more than 500 papers and articles published in the scientific literature and written or edited ten books on mental illness, psychopharmacology, and psychiatry. His contributions have established him as one of the most influential voices in contemporary psychiatric research and clinical practice.

Professional Recognition

Dr. Lieberman has received numerous national and international honors, including the Lieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders, the Adolph Meyer Award from the American Psychiatric Association, the Research Award from the National Alliance on Mental Illness, and the Neuroscience Award from the International College of Neuropsychopharmacology.

He is a member of the National Academy of Medicine and served as President of the American Psychiatric Association from 2013 to 2014, demonstrating his exceptional contributions to the field and his peers’ recognition of his expertise.